Evidence map›Paper›PMID 40165126›Full record

SynthesisBMC public health2025

Risk factors for progression to type 2 diabetes in prediabetes: a systematic review and meta-analysis.

Shengying Hu, Wenting Ji, Yizhu Zhang, Wendi Zhu, Hongyu Sun, Yumei Sun

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Integrative Clinical and Functional Characterization of theDiagnostics (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shengying Hu *School of Nursing, Peking University, Beijing, 100191, China.
Wenting Ji *Chengdu University of Traditional Chinese Medicine, 1166 Liutai Avenue, Wenjiang District, Chengdu, Sichuan, China.
Yizhu ZhangSchool of Nursing, Peking University, Beijing, 100191, China.
Wendi ZhuSchool of Nursing, Peking University, Beijing, 100191, China.
Hongyu SunSchool of Nursing, Peking University, Beijing, 100191, China. sunhongyu@bjmu.edu.cn.
Yumei SunSchool of Nursing, Peking University, Beijing, 100191, China. sym8022@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrediabetes is the earliest identifiable stage of glycemic dysregulation, and its progression can be delayed by effective control of risk factors. Currently, various risk factors for the progression from prediabetes to type 2 diabetes mellitus (T2DM) need to be further summarized.

objectiveThis systematic evaluation of the risk factors for the progression of prediabetes to type 2 diabetes mellitus provides a theoretical basis for early recognition and intervention. The meta-analysis identifies the Fatty Liver Index as a significant risk factor [OR = 6.14, 95% CI (5.22, 7.22)] for the progression from prediabetes to type 2 diabetes, highlighting its predictive value.

methodsPubMed, Web of Science, Embase, The Cochrane Library, CNKI, WANFANG, and VIP databases were searched to collect cohort studies on risk factors for progressing to type 2 diabetes in prediabetes from inception to February 15, 2024. STATA 17.0 was used for Meta-analysis.

resultsA total of 59 studies were included, all of which were of medium to high quality. The factors were categorized into four major groups: sociodemographic factors, lifestyle factors, psychosocial factors, and comorbidities and clinical indicators. Meta-analysis results showed that sociodemographic factors [age [OR = 1.03, 95% CI (1.01, 1.04)], family history [OR = 1.48, 95% CI (1.36, 1.61)], male sex [OR = 1.13, 95% CI (1.08, 1.19)], high BMI [OR = 1.21, 95% CI (1.15, 1.27)], high waist circumference [OR = 1.49, 95% CI (1.23, 1.79)], and high waist-to-hip ratio [OR = 2.44, 95% CI (2.17, 2.74)]]. Lifestyle factors included a lack of physical exercise [OR = 1.86, 95% CI (1.19, 2.88)], smoking [OR = 1.31, 95% CI (1.22, 1.41)], and moderate physical activity [OR = 0.24, 95% CI (0.09, 0.67)]. Psychosocial factors included anxiety [OR = 2.61, 95% CI (1.36, 5.00)], depression [OR = 1.88, 95% CI (1.35, 2.61)], and social deprivation level 4 [OR = 1.15, 95% CI (1.13, 1.18)]. Comorbidities and clinical indicators included hypertension [OR = 1.41, 95% CI (1.33, 1.50)], high triglycerides [OR = 1.25, 95% CI (1.10, 1.43)], high cholesterol [OR = 1.09, 95% CI (1.06, 1.12)], fatty liver index [OR = 6.14, 95% CI (5.22, 7.22)], low HDL-C [OR = 1.13, 95% CI (1.09, 1.36)], and high blood glucose levels [OR = 1.01, 95% CI (1.01, 1.02)].

conclusionsThis study found that age, male sex, positive family history of type 2 diabetes, high BMI, unhealthy lifestyle, anxiety, depression, high blood pressure, high triglycerides, and a high fatty liver index are risk factors for the progression from prediabetes to type 2 diabetes and should be given sufficient attention. Moderate physical activity and Low HDL-C are protective factors. Future studies should also increase follow-up, explore the best diagnostic criteria for prediabetes, and fully consider the definitions of various factors. The study was registered in PROSPERO (CRD42024513931).

Indexed as

Diabetes Mellitus, Type 2Disease ProgressionPrediabetic StateHumansRisk FactorsMeta-analysisPrediabetesRisk factorsSystematic ReviewType 2 diabetes mellitus

Identifiers

PMID40165126
PMCPMC11956339

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.